PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2018.3262019513901-909Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus CisplatinJaewon Hyung, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoohttp://e-crt.org/upload/pdf/crt-2018-326.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2018.326, http://www.e-crt.org/upload/pdf/crt-2018-326.pdf
Annals of Oncology10.1093/annonc/mdy151.105201829v29Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin chemotherapy: retrospective analysis of 142 patientsH. Enginhttps://api.elsevier.com/content/article/PII:S0923753419338426?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419338426?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/29/suppl_5/mdy151.105/25056826/mdy151.105.pdf
Annals of Oncology10.1093/annonc/mdt203.120201324iv70Gemcitabine Plus Cisplatin Versus Gemcitabine Chemotherapy for Advanced Biliary Tract CancerJinmyung Park, Jikon Ryuhttps://api.elsevier.com/content/article/PII:S0923753419546026?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419546026?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/24/suppl_4/iv70/6676803/mdt203.120.pdf
Asia-Pacific Journal of Clinical Oncology10.1111/ajco.12592201613113-20Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancerKwonoh Park, Kyu-pyo Kim, Seongjoon Park, Heung-Moon Changhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fajco.12592, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fajco.12592, http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12592/fullpdf
Annals of Oncology10.1093/annonc/mdz338.010201930vi92Clinical outcomes of gemcitabine, cisplatin plus S-1 in patients with advanced biliary tract cancerYusuke Niisato, Hiroyasu Ishida, Tsubasa Onoda, Yudai Shimoyamada, Yuka Ito, Takashi Yamaguchihttps://api.elsevier.com/content/article/PII:S0923753419621058?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419621058?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/30/Supplement_6/mdz338.010/30115638/mdz338.010.pdf, http://academic.oup.com/annonc/article-pdf/30/Supplement_6/mdz338.010/30115638/mdz338.010.pdf
Annals of Oncology10.1093/annonc/mdu334.108201425iv245Gemcitabine Plus Cisplatin Versus Capcitbine Plus Cisplatin for Locally Advanced or Metastatic Biliary Tract CancerK. Park, K. Kimhttps://api.elsevier.com/content/article/PII:S0923753419520476?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419520476?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/25/suppl_4/iv245/9690351/mdu334.108.pdf
Annals of Oncology10.1093/annonc/mdt459.13201324ix33Second-Line Therapy of S-1 for Patients with Advanced Biliary Tract Cancer After Failure to Cisplatin Plus GemcitabineS. Kobayashi, M. Ueno, S. Ohkawa, Y. Gouda, K. Irie, M. Morimotohttps://api.elsevier.com/content/article/PII:S0923753419331898?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0923753419331898?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/24/suppl_9/ix33/6676541/mdt459.13.pdf
Yearbook of Surgery10.1016/s0090-3671(10)79889-x20112011310-312Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerT.J. Eberleinhttps://api.elsevier.com/content/article/PII:S009036711079889X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S009036711079889X?httpAccept=text/plain
Yearbook of Gastroenterology10.1016/s0739-5930(10)79580-52010201096-97Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerR.K. Pearsonhttps://api.elsevier.com/content/article/PII:S0739593010795805?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0739593010795805?httpAccept=text/plain
Chemotherapy10.1159/0003545392013593232-238Gemcitabine plus Cisplatin versus Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Cohort StudySang Myung Woo, Woo Jin Lee, Ji Hun Kim, Dong Hwan Kim, Sung-Sik Han, Sang-Jae Park, Tae Hyun Kim, Ju Hee Lee, Young Hwan Koh, Eun Kyung Honghttps://www.karger.com/Article/Pdf/354539, https://www.karger.com/Article/Pdf/354539